Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THRIVE-yeast
NCT04930107Phase 1Active, not recruiting
- Sponsor
- University of Manitoba
- Start
- Dec 2021
- Primary completion
- Apr 2029
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 1, open-label trial of boric acid in vulvovaginal candidiasis (VVC) (4 arms), sponsored by University of Manitoba. Primary endpoint: Fungal Diversity at 1 month. Started Dec 2021; status: active, not recruiting.
02
Drugs
boric acid
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on NCT04930107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04930107.